Zhengye Biotechnology Holding (ZYBT) Non-Current Debt (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Non-Current Debt of $1.2 million for Q4 2025, up 86.73% year-over-year from $668235.5 in Q4 2024, and up 90.21% quarter-over-quarter from $656000.0 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Non-Current Debt (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Non-Current Debt for 3 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Debt rose 86.73% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (up 86.73% YoY), while the FY2025 annual figure was $1.3 million, up 92.4% from the prior year.
- Non-Current Debt advanced to $1.2 million in Q4 2025 per ZYBT's latest filing, from $656000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $1.4 million in Q4 2023 and bottomed at $656000.0 in Q2 2025.
- Historically, Non-Current Debt has averaged $989876.3 across 3 years, with a median of $958010.0 in 2024.
- Annual changes were most pronounced in 2024 — Non-Current Debt tumbled 51.84% — and 2025, when it soared 86.73%.
- Zhengye Biotechnology Holding's Non-Current Debt stood at $1.4 million in 2023, then sank by 51.84% to $668235.5 in 2024, then jumped by 86.73% to $1.2 million in 2025.
- Business Quant data shows ZYBT's Non-Current Debt at $1.2 million in Q4 2025, $656000.0 in Q2 2025, and $668235.5 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 130.00 Mn |
| 10 | Zhengye Biotechnology Holding | 88.82 Mn | 81.50 Mn | - | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.25 Mn |
| Jun 30, 2025 | 656,000.00 |
| Dec 31, 2024 | 668,235.45 |
| Dec 31, 2023 | 1.39 Mn |